K-numberK250328
Device nameUltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program
ApplicantCanon Medical Systems Corporation
Product codeQIH
Device classClass II
Decision dateApr 30, 2025
DecisionSubstantially Equivalent
Regulation892.2050
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The UltraExtend NX V2.0 is ultrasound image analysis software that allows physicians and trained clinical staff to observe and analyze ultrasound images in hospital and clinical settings. It processes examination data acquired from Canon's Aplio i900/i800/i700 diagnostic ultrasound systems, accepting RAW data or Image + RAW formats for post-processing and measurement.

Technological characteristics

The subject device employs the same fundamental scientific technology as the predicate device (UltraExtend FX V2.02) and provides identical software features except for expanded measurement packages (Standard, Application, Obstetrics), enhanced Cardiac4D capabilities, and new AI/ML-enabled features including 2D/3D Wall Motion Tracking, Auto EF with left ventricle full-assist, left atrial analysis, Aortic Valve Analysis, Smart Fetal Heart, Flex-M, and Vascularity Index. The AI/ML functions were integrated without modification from a reference device (Aplio i900/i800/i700 K223017).

Test standards cited

IEC 62304 Edition 1.1 (2015-06) medical device software lifecycle processes; IEC 62366-1 Edition 1.1 (2020-06) usability; ISO 13485 quality management; 21 CFR 820 Quality System Regulations. Software documentation followed FDA guidance on device software functions (June 14, 2023) and cybersecurity considerations (September 27, 2023).

Substantial equivalence argument

The subject device is substantially equivalent because it has identical clinical intended use (post-processing of ultrasound data), the same fundamental technology, and identical core functionality to the predicate, with differences only in expanded features and AI/ML capabilities. Performance testing using representative clinical datasets and the same acceptance criteria as the reference device demonstrated these expanded features perform as intended with substantial equivalence. The integration of pre-cleared AI/ML functions without modification, combined with identical basic functionality and intended use, establishes substantial equivalence despite the expanded feature set.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →